Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Hypoxic VDAC1: A Potential Mitochondrial Marker for Cancer Therapy

Include preview-only content
  1. Article

    Open Access

    The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment

    Medulloblastoma is a cancerous brain tumor that affects mostly children. Among the four groups defined by molecular characteristics, Group 3, the least well characterized, is also the least favorable, with a s...

    J. Contenti, Y. Guo, A. Mazzu, M. Irondelle, M. Rouleau, C. Lago in Cell Death & Disease (2023)

  2. Article

    Open Access

    Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells

    Cancer cells are characterized by the Warburg effect, a shift from mitochondrial respiration to oxidative glycolysis. We report here the crucial role of cyclin D1 in promoting this effect in a cyclin-dependent...

    M. Caillot, J. Bourgeais, H. Dakik, É. Costé, N. M. Mazure, É. Lelièvre in Oncogenesis (2020)

  3. Article

    Open Access

    MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

    The resistance of hypoxic cells to radiotherapy and chemotherapy is a major problem in the treatment of cancer. Recently, an additional mode of hypoxia-inducible factor (HIF)-dependent transcriptional regulati...

    S Grosso, J Doyen, S K Parks, T Bertero, A Paye, B Cardinaud in Cell Death & Disease (2013)

  4. Article

    miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

    Following the identification of a set of hypoxia-regulated microRNAs (miRNAs), recent studies have highlighted the importance of miR-210 and of its transcriptional regulation by the transcription factor hypoxi...

    M-P Puisségur, N M Mazure, T Bertero, L Pradelli, S Grosso in Cell Death & Differentiation (2011)

  5. Article

    Open Access

    High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

    Carbonic anhydrase IX (CAIX) is an enzyme upregulated by hypoxia during tumour development and progression. This study was conducted to assess if the expression of CAIX in tumour tissue and/or plasma can be a ...

    M İlie, N M Mazure, V Hofman, R E Ammadi, C Ortholan in British Journal of Cancer (2010)